To help babies have a better developmental outcome, Cincinnati Children’s is launching the NICU Bookwork Program to help parents bond with their newborns through books.
Cincinnati Children’s researcher hope the Pediatric Asthma Risk Score (PARS) will become the most common tool used by medical practitioners to predict asthma.
After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults. Punam Malik, MD, is the principal investigator.
A daily hydroxyurea pill may bring relief for young children living with sickle cell anemia (SCA) in sub-Saharan Africa, says study in The New England Journal of Medicine led by Russell Ware, MD, PhD.
A new study, led by David Schnadower, MD, and published in The New England Journal of Medicine, shows that a commonly used probiotic is not effective in improving symptoms in young patients with gastroenteritis.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2018 Cincinnati Children's Hospital Medical Center. All rights reserved.